Clinical trial
Safety and Pharmacokinetics of ODM-209
NCT03878823
Study timeline
Study start (actual)2019-04-17Date precision: day
Registry last updated2024-02-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Cancer Metastaticunresolved
Advanced Breast Cancerunresolved
Castration-resistant Prostate Cancerunresolved
Metastatic Breast Cancerunresolved
Interventions
ODM-209DRUG
Sponsors & collaborators
Orion Corporation, Orion Pharmalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03878823 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.